ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 299883

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Röllinghoff M and 3 others. J Exp Med, 1977. Cited by 400 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. Papers, record 299883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/299883

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.
PubMed
Journal
J Exp Med
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
400
iCite
Relative citation ratio, by iCite
9.87
iCite
Revised in PubMed
2021-12-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Röllinghoff MM
2Starzinski-Powitz AA
3Pfizenmaier KK
4Wagner HH

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
Immunity, CellularMajor topic
T-LymphocytesMajor topic
Animals
Cytotoxicity Tests, Immunologic
Histocompatibility Antigens
Immunosuppression Therapy
Mice
Trinitrobenzenes

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1135,689T cell proliferation in the mixed lymphocyte culture does not necessarily result in the generation of cytotoxic T effector cells.Eur J Immunol1975https://conductscience.org/library/papers/135689PubMed
24,151,339Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.Adv Immunol1974https://conductscience.org/library/papers/4151339PubMed
34,151,904T-cell-mediated immune responses induced in vitro: a probe for allograft and tumor immunity.Transplant Rev1973https://conductscience.org/library/papers/4151904PubMed
44,587,740A rapid method for the isolation of functional thymus-derived murine lymphocytes.Eur J Immunol1973https://conductscience.org/library/papers/4587740PubMed
51,117,258Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.J Exp Med1975https://conductscience.org/library/papers/1117258PubMed
64,598,017Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.J Exp Med1974https://conductscience.org/library/papers/4598017PubMed
71,084,997Role of major histocompatibility complex gene products in delayed-type hypersensitivity.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1084997PubMed
81,084,407Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.J Exp Med1976https://conductscience.org/library/papers/1084407PubMed
91,082,923Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against H-2 incompatible target cells.J Exp Med1976https://conductscience.org/library/papers/1082923PubMed
1052,120Are contact hypersensitivity cells cytotoxic?Nature1975https://conductscience.org/library/papers/52120PubMed

Cited by94

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 400 citations.

PMIDTitleJournalYearIn PapersSource
42,921,550Advancing T Cell Engagers in Multiple Myeloma: Structural Design and Clinical Optimization to Address Current Limitations.Drug Des Devel Ther2026https://conductscience.org/library/papers/42921550PubMed
39,266,530Bispecific antibodies in the treatment of multiple myeloma.Blood Cancer J2024https://conductscience.org/library/papers/39266530PubMed
36,980,705Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety.Cancers (Basel)2023https://conductscience.org/library/papers/36980705PubMed
33,906,820Tumor resident regulatory T cells.Semin Immunol2021https://conductscience.org/library/papers/33906820PubMed
32,721,424Animal models of high-risk corneal transplantation: A comprehensive review.Exp Eye Res2020https://conductscience.org/library/papers/32721424PubMed
32,309,787Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma.Hemasphere2020https://conductscience.org/library/papers/32309787PubMed
27,141,331Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.Oncoimmunology2016https://conductscience.org/library/papers/27141331PubMed
22,910,667Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains.Parasite2012https://conductscience.org/library/papers/22910667PubMed
22,120,986Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity.Bone Marrow Transplant2012https://conductscience.org/library/papers/22120986PubMed
21,789,035Cornea: Window to Ocular Immunology.Curr Immunol Rev2011https://conductscience.org/library/papers/21789035PubMed

1 to 10 of 94

See all 94 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/299883

GET https://conductscience.org/api/papers/v1/299883/cited_by?page=2

API referenceFor AI assistants